GOJIRED®

Identification & Functionality

Active Component

Carotenoids,

Zeaxanthin

INCI Name

Lycium Barbarum Fruit Extract

Ingredient Origin

Natural Origin,

Non-Animal Origin,

Plant Origin

Cosmetic Ingredients Functions

Anti-Inflammatory

CAS No.

85085-46-7

EC No.

285-375-0

Technologies

Cosmetic Ingredients

Product Families

Cosmetic Ingredients — Cosmetic Actives

Skin Actives

Cosmetic Ingredients — Vitamins, Extracts & Oils

Botanical Ingredients & Extracts

Features & Benefits

Benefit Claims

Anti-Inflammatory,

Oxidation Protection,

UV Protection

Labeling Claims

Clean at Sephora,

Credo Clean Standard,

Naturally Derived,

Plant-Based,

Ulta Beauty's Conscious Beauty

Applications & Uses

Markets

Personal Care

Applications

Personal Care — Beauty & Care

Skin Care,

Sun Care

Applications

• Due to its biological properties and the high level of carotenoids, Gojired® can be used as an innovative ingredient to prevent cognitive disorders, mental impairments, neurodegenerative diseases and oxidative damages.
• The antioxidant properties have been evaluated and tested in collaboration with University of Calabria using ORAC DPPH ABTS: Gojired® extract obtained from Calabrian Goji has higher levels of carotenoids expressed as zeaxanthin compared to other goji extracts, probably due to the sun exposure and the Mediterranean climatic conditions of Sibari Plain.Moreover, for its carotenoid content, Gojired® can be used in cosmetic application for skin photoprotection, reducing UV-induced free radicals.

Properties

Physical Form

Powder,

Solid

Regulatory & Compliance

Certifications & Compliance

GMP,

ISO 9001

Technical Details & Test Data

Bibliography

• Pharmacopeia Hungarica, 7th ed. Budapest, Hungarian Pharmacopeia Commission, Medicina Kanyvkiado, 1986. 3. Bedevian AK. Illustrated polyglottic dictionary of plant names in Latin, Arabic, Armenian, English, French, German, Italian and Turkish languages. Cairo, Argus & Papazian Press, 1936. 4. Hänsel R et al., eds. Hagers Handbuch der pharmazeutischen Praxis. BD. 6: Drogen P-Z, 5th ed. Berlin, Springer-Verlag, 1994.
• British herbal pharmacopeia. London British Herbal Medicine Association, 1996.
• Farnsworth NR, ed. NAPRALERT database. Chicago, University of Illinois at Chicago, IL, February 9, 1998 production (an online database available directly through the University of Illinois at Chicago or through the Scientific and Technical Network (STN) of Chemical Abstracts Services).
• Bisset NG. Herbal drugs and phytopharmaceuticals. Boca Raton, FL, CRC, CRC Press, 1994.
• Youngken HW. Textbook of Pharmacognosy, 6th ed. Philadelphia, PA, Blakiston, 1950.
• Backer CA, Backhuisen van der Brink RC, eds. Flora of Java. Vol. 2. Noordhof, NVP, 1965.
• Quality control methods for medicinal plant materials. Geneva, World Health Organization, 1998.
• European pharmacopeia, 3rd ed. Strasbourg, Council of Europe, 1996.
• Guidelines for predicting dietary intake of pesticide residues, 2nd rev. ed. Geneva, World Health Organization (document WHO/FSF/FOS/97.7). OMS: monografie di piante medicinali 186
• ESCOP monographs on the medicinal use of plant drugs. Fascicule 1. Elburg, European Scientific Cooperative on Phytotherapy, 1996. 15. Blumenthal M et al., eds. The complete German Commission E monographs. Austin, TX, American Botanical Council, 1998.
• Wöbling RH, Milbradt R. Klinik und Therapie des Herpes simplex. Der Allgemainarzt. Vorstellung eines neuen phytotherapeutischen Wirkstoffes. Therapiewoche, 1984, 34:1193-1200.
• Vogt HJ et al. Melissenextrakt bei Herpes simplex. Allgemeinarzt, 1991, 13:832-841.
• Wölbling RH, Leonhardt K. Local therapy of herpes simplex with dried extract from Melissa officinalis. Phytomedicine, 1994, 1:25-31
• JOON-SIK KIM ET AL.: ‘Screening of Anti-angiogenic Activity from Plant Extracts’ KOR. J. PHARMACOGN. vol. 37, no. 4, 2006, pages 253 – 257